Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.7493
Delayed Data
As of Mar 26
 -0.0407 / -5.15%
Today’s Change
0.73
Today|||52-Week Range
4.89
-53.17%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +1,101.12% increase from the last price of 0.75.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$16.0K
Reporting Date
Mar 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.00%
 
 
 
 
 
 
Growthannually 72.22%
 
 
 
 

Sales

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually -81.70%
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account